Category: BD

  • PharmaShots Weekly Snapshots (July 26 – 30, 2021)

    Roche Publishes the Results of Evrysdi (risdiplam) in FIREFISH Study to Treat of Type 1 SMA at NEJM Published: July 30, 2021 | Tags: Roche, Evrysdi, risdiplam, FIREFISH Study, Type 1 SMA, NEJM BeiGene Reports Results of Brukinsa (zanubrutinib) in P-III SEQUOIA Trial for the Treatment of Chronic Lymphocytic Leukemia Published: July 30, 2021 | […]

  • BD Acquires Tepha to Boost its Surgical Mesh Portfolio

    Shots: The acquisition will utilize Tepha’s resorbable polymer technology to boost the growth of BD’s surgical mesh portfolio for the repair and regeneration of soft tissues The acquisition also provides strategic vertical integration for BD’s Phasix mesh products & includes Tepha’s GalaFLEX portfolio which is based on the novel P4HB polymer Additionally, an interventional segment […]

  • Top 20 Medical Device Companies Based on 2020 Revenue

    The medical devices industry is a fast-growing market driven by the complex needs of patients encouraging life science companies to develop innovative therapies to improve health and QoL In 2020, the companies have shown growth resulted from a rise in the number of healthcare facilities, healthcare expenditure, technological advancements. Medtronic remains at the top of […]

  • BD to Spin Off its Diabetes Care Business into New Public Company

    Shots: The spin-off of the Diabetes Care business will allow the BD to strengthen its growth profile, enables it to focus on its other core businesses. The transaction is expected to be completed in H1’22 Standalone Diabetes Care business is expected to leverage its position as a global leader in insulin delivery and expand its […]

  • PharmaShots Weekly Snapshots (Nov 09-13, 2020)

    Qiagen Launches Portable Digital SARS-CoV-2 Antigen Test in the US Published: Nov 13,2020 | Tags: Antigen Test, Digital, Launches, Portable, Qiagen, SARS-CoV-2, US GSK and Medicago Initiate P-II/III Study of its Plant-Derived COVID-19 Vaccine Published: Nov 13,2020 | Tags: COVID-19, GSK, Initiate, Medicago, P-II/III, Plant- Derived study, vaccine BD Acquires the Medical Business Assets of […]

  • BD Acquires the Medical Business Assets of CUBEX

    Shots: The acquisition expands the BD’s medication management offerings into the care continuum space and provides deeper integration with EHRs The Medical Business of CUBEX’s key offering is a cloud-based software supporting decentralized medication management and provides unique features specialized for pharmacists and nurses across the care continuum With the acquisition, 40 CUBEX’s associates will […]